Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for Vitamin K antagonist reversal in a real-world setting
Ranjit Joseph
, James Burner
, Sean Yates
, Amanda Strickland
, William Tharpe
, Ravi Sarode
Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for Vitamin K antagonist reversal in a real-world setting'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prothrombin Complex Concentrate
100%
Vitamin K Antagonists
100%
Unselected Patients
40%
United States
20%
Study Support
20%
Multivariate Analysis
20%
Hospitalization
20%
High Risk
20%
Antiphospholipid Syndrome
20%
Randomized Clinical Trial
20%
Consecutive Patients
20%
Thrombotic Complications
20%
Hypercoagulable State
20%
Factor V Leiden
20%
Thrombosis Risk
20%
Active Malignancy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Thromboembolism
100%
Antivitamin K
100%
Prothrombin Complex
100%
Antiphospholipid Syndrome
14%
Thrombosis
14%
Randomized Clinical Trial
14%
Blood Clotting Factor 5 Leiden
14%